Analysts expect Phibro Animal Health Corporation (NASDAQ:PAHC) to report $0.44 EPS on May, 7 after the close.They anticipate $0.07 EPS change or 18.92% from last quarter’s $0.37 EPS. PAHC’s profit would be $17.68M giving it 24.69 P/E if the $0.44 EPS is correct. After having $0.44 EPS previously, Phibro Animal Health Corporation’s analysts see 0.00% EPS growth. The stock decreased 1.14% or $0.5 during the last trading session, reaching $43.45. About 27,711 shares traded. Phibro Animal Health Corporation (NASDAQ:PAHC) has risen 41.44% since April 19, 2017 and is uptrending. It has outperformed by 29.89% the S&P500.
Among 14 analysts covering Trinity Industries (NYSE:TRN), 8 have Buy rating, 4 Sell and 2 Hold. Therefore 57% are positive. Trinity Industries had 42 analyst reports since September 4, 2015 according to SRatingsIntel. Stifel Nicolaus maintained it with “Hold” rating and $22 target in Wednesday, November 30 report. The stock of Trinity Industries, Inc. (NYSE:TRN) earned “Buy” rating by KeyBanc Capital Markets on Friday, September 15. The stock of Trinity Industries, Inc. (NYSE:TRN) earned “Neutral” rating by Longbow on Monday, June 20. The rating was maintained by Stifel Nicolaus with “Hold” on Friday, September 30. KeyBanc Capital Markets maintained Trinity Industries, Inc. (NYSE:TRN) rating on Monday, October 2. KeyBanc Capital Markets has “Buy” rating and $41.0 target. The stock has “Buy” rating by Cowen & Co on Tuesday, October 17. Cowen & Co maintained it with “Buy” rating and $31.0 target in Friday, September 29 report. On Monday, December 14 the stock rating was initiated by Cowen & Co with “Outperform”. The rating was downgraded by Stifel Nicolaus to “Hold” on Tuesday, April 19. The firm has “Outperform” rating given on Friday, February 16 by Wells Fargo. See Trinity Industries, Inc. (NYSE:TRN) latest ratings:
06/03/2018 Broker: Vertical Research Rating: Sell New Target: $20 Initiates Coverage On
23/02/2018 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Buy Old Target: $40 New Target: $42 Maintain
20/02/2018 Broker: Susquehanna Rating: Buy New Target: $52.0 Maintain
16/02/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Outperform Upgrade
09/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $40.0 Maintain
04/01/2018 Broker: Seaport Global Rating: Neutral Initiates Coverage On
22/12/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $43.0 Maintain
12/12/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $42.0 Maintain
13/12/2017 Broker: Cowen & Co Rating: Buy New Target: $46.0 Maintain
06/11/2017 Broker: Susquehanna Old Rating: Neutral New Rating: Positive Upgrade
Since February 9, 2018, it had 0 buys, and 13 selling transactions for $12.62 million activity. The insider Miller Larry Lee sold 17,928 shares worth $630,886. Shares for $1.40 million were sold by BENDHEIM JACK. 23,163 shares were sold by Bendheim Daniel M, worth $926,717. The insider Warras Dean J sold $356,200. On Wednesday, March 14 the insider BFI Co. – LLC sold $961,200.
Among 9 analysts covering Philbro Animal Health (NASDAQ:PAHC), 3 have Buy rating, 4 Sell and 2 Hold. Therefore 33% are positive. Philbro Animal Health had 19 analyst reports since September 30, 2015 according to SRatingsIntel. The company was maintained on Friday, July 21 by Piper Jaffray. The firm has “Outperform” rating given on Thursday, February 4 by Credit Suisse. The stock of Phibro Animal Health Corporation (NASDAQ:PAHC) earned “Outperform” rating by Credit Suisse on Thursday, August 31. Barclays Capital downgraded Phibro Animal Health Corporation (NASDAQ:PAHC) rating on Monday, January 18. Barclays Capital has “Underweight” rating and $31 target. The company was initiated on Thursday, December 15 by Piper Jaffray. Piper Jaffray maintained the shares of PAHC in report on Friday, October 6 with “Buy” rating. On Tuesday, October 13 the stock rating was upgraded by KeyBanc Capital Markets to “Overweight”. The firm has “Buy” rating given on Wednesday, February 7 by Piper Jaffray. Gabelli initiated Phibro Animal Health Corporation (NASDAQ:PAHC) rating on Wednesday, September 30. Gabelli has “Buy” rating and $42.0 target. The firm has “Hold” rating given on Thursday, November 10 by Gabelli.
Investors sentiment decreased to 1.41 in 2017 Q4. Its down 0.07, from 1.48 in 2017Q3. It turned negative, as 17 investors sold Phibro Animal Health Corporation shares while 42 reduced holdings. 25 funds opened positions while 58 raised stakes. 19.14 million shares or 1.25% less from 19.38 million shares in 2017Q3 were reported. California State Teachers Retirement Sys has invested 0% in Phibro Animal Health Corporation (NASDAQ:PAHC). Los Angeles Cap Mgmt Equity Rech Inc invested in 0.01% or 65,425 shares. Martingale Asset Mgmt L P holds 0.05% or 123,043 shares. Spark Invest Mgmt Ltd has 47,500 shares. Pnc Fin Service Group Inc invested in 0% or 471 shares. Goldman Sachs, a New York-based fund reported 476,391 shares. 6,679 were reported by Teacher Retirement Systems Of Texas. Parametric Assoc Limited Liability Company has 55,820 shares. The Pennsylvania-based Ajo Ltd Partnership has invested 0.03% in Phibro Animal Health Corporation (NASDAQ:PAHC). 2.74M were accumulated by Blackrock. U S Global Invsts reported 23,900 shares. Millennium Management Limited Liability Co owns 419,998 shares. Ameritas Prns Incorporated reported 1,619 shares or 0% of all its holdings. Schwab Charles Investment Management Incorporated owns 146,967 shares for 0% of their portfolio. 308,779 are owned by Aqr Capital Mngmt Limited Company.
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition firm primarily in the United States. The company has market cap of $1.75 billion. It operates through three divisions: Animal Health, Mineral Nutrition, and Performance Products. It has a 28.25 P/E ratio. The firm develops, makes, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.
The stock decreased 1.03% or $0.33 during the last trading session, reaching $31.6. About 584,507 shares traded. Trinity Industries, Inc. (NYSE:TRN) has risen 25.06% since April 19, 2017 and is uptrending. It has outperformed by 13.51% the S&P500.
Since October 26, 2017, it had 6 insider purchases, and 0 insider sales for $118.07 million activity. Shares for $10.10M were bought by ValueAct Holdings – L.P. on Tuesday, March 6.